To Clinician

2018 The 23rd Taiwan Joint Cancer Conference

2018/05/12

Dr Giordano, Lai and Kakudo

Meuseum visit

Professor Giordano (University of Michigan) and I were invited to have 2 lectures each in the 23rd Taiwan Joint Cancer Conference, being held in Taipei on 6th of May, 2018. We enjoied beautiful seanry of Taiwan and deep histry of China (Figure). The conference PPT files are available at http://www.twiap.org.tw/teach/content.asp?ID=1231&FDType=36. Lecture notes for my two lectures were published in the J Basic Clin Med (http://sspublications.org/index.php/JBCM) .

category: To Clinician , To pathologist comment: (0)

Special Issue in J Pathol Translational Medicine

2017/11/22

The Working Group of Asian Thyroid FNA Cytology had several projects and one of them become visible.  I would like to announce a special issue of Journal of Pathology and Translational Medicine on Current Practices of Thyroid Fine-Needle Aspiration in Asia (http://jpatholtm.org/current/?vol=51&no=6​).  Nine authors from our Working Group published their practices introducing their practice in details. I believe this special issue will be a good sources in the future when refere thyroid practice in Asian countries.

category: To Clinician , To pathologist comment: (0)

Borderline Thyroid Tumors in WHO Classification of Endocrine Organs

2017/08/21

4th edition WHO Classification

4th edition WHO Classification

The 4th edition of WHO Classification Tumors of Endocrine Organs was published in July, 2017. Borderline tumors of follicular cell origin were incotporated in this thyroid tumor classification very first time. I hope the introduction of the borderline tumor category in thyroid tumor classification will open a new era where pathologists have 3 choices for their diagnoses: benign, borderline, or malignant. Pathologists are no longer forced to decide between benign and malignant—it can be a borderline or precursor tumor. I believe this causes significant changes not only in pathology practice, but also brings significant impacts on clinical management of patients. It opens a new era for endocrinologists and endocrine surgeons to have 3 treatment options for patients with thyroid nodules, treat, not treat, or close follow-up (active surveillance), which would be different from the current clinical management with 2 choices (treat or not treat).  

Borderline/Precursor Tumours in the 4th Edition, 2017 WHO Classification of Thyroid Tumours.

2

Hyalinizing Trabecular Tumour

2A

Other encapsulated follicular patterned thyroid tumours

2A-1

Uncertain malignant potential (UMP)

2A-1-1:Follicular tumour of Uncertain malignant potential (FT-UMP)

2A-1-2:Well differentiated tumour of Uncertain malignant potential (WDT-UMP)

2A-2

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)

category: To Clinician , To pathologist , To Patient comment: (2)

NIFTP Special Issue in JBCM.

2017/03/19

I have published a special issue on NIFTP (non-invasive encapsulated follicular neoplasm with papillary-like nuclear features) in the Journal of Basic and Clinical Medicine (http://www.sspublications.org/index.php/JBCM/index). This is a very first special issue focussing on NIFTP in any scientific journals, and which covered both histological and cytological aspects. It is also characterized by international authors from 8 countries, Eastern and Western practice. This approach elucidated significal differences between the two practice. Please enjoy find those differences and underlining different way of thinking and logics.

category: To Clinician , To pathologist , To Patient comment: (0)

Working Group of Asian Thyroid FNA Cytology

2017/03/19

WG

18th AOTA

On March 16th. a symposium conducted by Working Group of Asian Thyroid FNA Cytology was held in Busan, Korea conjointed with the 18th International Congress of Asia Oceania Thyroid Association.  Please refere to a wechat by Dr Liu at  http://mp.weixin.qq.com/s/u5HCPPZMXGoV2wdlJ7OTlg There were 11 presentations by 10 cytopathologists from 6 (Korea, Taiwan, China, Thailand, Turkey and Japan) countries, which elucidate differences between Asian and Western practice and unsolved issues in the newly introduced tumor entity, NIFTP. Particularlly on observer valiation among reviewers on papillary thyroid carcinoma type nuclear features was reported by Dr Liu and low rates of NIFTP in Asian practice was reported by Andrey Bychkov.

category: To Clinician , To pathologist comment: (0)